Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
The release does not mention cost or whether it’s covered by private insurance or Medicare, and in this case, it’s a pretty big omission. This may be an enormously expensive treatment for patients — and it’s why we have a cost criterion in our reviews. The hopeful psoriasis patient who sees this release without a cost discussion might already have their hand on the phone to call their dermatologist. Here’s a very rough estimate of what that patient might face in terms of cost: Based on a conservative wholesale price of roughly $4,000 per 80 mg injection and following the recommendation (found on the package insert) of two injections every two weeks for 12 weeks, followed by monthly injections, we calculated $48,000 for the first 12 weeks plus $36,000 for the following 9 months or $84,000 total. The release stated that by week 12, “76.4 to 81.8 percent of patients had their psoriasis classified as “clear” or “minimal” compared to 3.2% of patients on the placebo. By the 60th week, 68.7 to 78.3 percent of patients had maintained their improvement.” We also wanted more detail on the measured strength of the response for each patient. For example, what constitutes “minimal”? The release adequately addresses harms and notes that long-term side effects are unknown with this sentence: “Adverse events associated with ixekizumab included slightly higher rates of neutropenia (low white blood cell count), yeast infection and inflammatory bowel disease compared to the placebo. The safety of therapy longer than 60 weeks will need to be monitored in the future.” The release clearly and thoroughly describes the three phase 3 international trials at 21 sites, that they enrolled a large number of patients, and that they were randomized and controlled. There was no disease mongering. The release describes what psoriasis is and its prevalence, and explains that these trials were for moderate to severe psoriasis which covers at least 10 percent of the body. The release is very transparent in stating that the drug manufacturer paid for the research and that the lead researcher is a paid consultant to Eli Lilly. The release did not compare the many different ways that patients treat psoriasis, some with topical agents and some with oral steroids or other medications. The release states that the drug has been approved by the FDA following the completion of the trials. This is a strong indication that the drug is or soon will be available. The release should have noted that the drug is already being marketed under the brand name Taltz. The release makes an understated claim to novelty with this quote from the lead researcher: “Ten years ago, we thought complete clearance of this disease was impossible. It wasn’t something we would even try to do. Now with this drug, we’re obtaining response levels higher than ever seen before.” There was no unjustifiable language in the release.

Ex Output:
New drug clears psoriasis in clinical trials


Ex Input:
Although some of these infections can be treated easily, others - like the superbug MRSA and other drug-resistant bugs - can be fatal or affect patients’ health very seriously, taking several months of costly hospital care and medication to beat. A survey by the European Centre for Diseases Prevention and Control (ECDC) found that on any given day, one in 18 patients in European hospitals has at least one hospital-acquired infection - amounting to around 3.2 million patients per year. “Healthcare-associated infections pose a major public health problem and a threat to European patients,” said Marc Sprenger, director of the Stockholm-based ECDC. He said many of these infections could be prevented by well thought-out, sustained and multi-pronged prevention and control programs and he urged hospitals to step up the fight. “Such programs, as well as prudent use of antibiotics, will help all actors involved to protect the patients of European hospitals,” he said in a statement. The ECDC warned last year that doctors are increasingly having to turn to last-ditch antibiotics due to growing drug-resistant superbug infections in Europe - many of them acquired in hospitals. The latest survey, which covered 1,000 hospitals in 30 European countries, found the highest rates of hospital-acquired infections were among patients admitted to intensive care units, where 19.5 percent of patients had at least one bug they had picked up from the hospital. The most common types of infection are respiratory tract infections such as pneumonia and infections of the bloodstream. These are often caused by Klebsiella pneumonia and E. coli bacteria, both of which have shown an ability to develop resistance to some of the most powerful antibiotics. Among a total 15,000 reported healthcare-associated infections, surgical site infections and urinary tract infections are also common. Many of the infections are also found to be drug-resistant “superbugs”, the survey showed. Among all infections with Staphylococcus aureus bacteria in which full testing was carried out, more than 40 percent were reported as resistant to methicillin - in other words they were MRSA infections, the ECDC said. Worldwide, MRSA infects an estimated 53 million people annually and costs more than $20 billion a year to treat. It kills around 20,000 people a year in the United States and a similar number in Europe. EU health and consumer affairs commissioner Paola Testori Coggi said the findings of the European survey were “worrying” and urged health authorities to do more to protect patients in hospital and to step up the fight against antibiotic resistance. Drug resistance is driven by the misuse and overuse of antibiotics, which encourages bacteria to develop new ways of overcoming them. Experts say hospitals are often guilty of overusing antibiotics, giving them as “blanket” treatments before full testing has established which drugs are really needed.

Ex Output:
Three million Europeans catch infections in hospital annually.


Ex Input:
Legislators signed off on the special voting provisions for the 2020 elections shortly before their deadline to pass bills in an unusual session that was interrupted for several weeks because of concerns about the virus that causes COVID-19. Voters currently can request absentee ballots only if they provide an excuse for why they can’t vote in person. Illness is one option, but the law isn’t explicit on whether the illness excuse covers healthy voters concerned about catching or spreading COVID-19. Under the bill sent to Republican Gov. Mike Parson, people considered at-risk of the coronavirus — those age 65 and older, living in a long-term care facility or with certain existing health problems — could vote absentee without needing to have their ballot notarized. Anyone else could cast a mail-in ballot but would need to get it notarized. The bill passed with bipartisan support but received mixed reviews from both parties. Republicans said it doesn’t include enough restrictions to ensure election security, and Democrats said it has too many rules. “When you are not wanting to go to the polls because you are either ill or fearful of becoming ill, but then you have to go get a notary to be able to not go to the polls, it doesn’t really fix the problem,” House Democratic Minority Leader Crystal Quade said. Republican Secretary of State Jay Ashcroft on Friday said he no longer supported the measure after lawmakers stripped a contested photo ID requirement out of it. Lawmakers returned to the Capitol to work on the state budget and other policies days before Parson lifted his statewide stay-at-home order in early May. Members of the public were allowed in the Capitol to watch debate but were encouraged to stay home, prompting concern from some lawmakers about lack of public involvement in crafting major policy changes. Both lawmakers and visitors were quizzed on their health and had their temperatures checked before they could enter the building. “The work that we did here today I think was important enough that legislators made the decision that they were going to go ahead and come to the building to do work,” Republican House Speaker Elijah Haahr said. “We understand the risks involved.” Few lawmakers wore masks in the final days of session, and legislators frequently sat close to one another to vote. Lawmakers also faced pressure to act on crime legislation following a bloody 2019 and a violent start to 2020. The deaths of two men on Tuesday night were Kansas City’s 63rd and 64th homicides this year. St. Louis police reported 53 homicides as of Friday. A bill headed to Parson’s desk would create the crime of vehicle hijacking, expand the number of crimes that are considered dangerous felonies, ban probation for some crimes, and broaden what’s considered a criminal street gang, along with increased penalties for taking part in gang activities. “This is going to help get the most violent habitual offenders off of the streets,” Republican Rep. Nick Schroer said. The bill sparked outrage from House lawmakers who said it could reverse a drop in the state’s prison population following a bipartisan push for criminal justice reform in recent years. “It doesn’t make us safer,” Republican Rep. Shamed Dogan said of longer prison sentences. “It sounds good in campaign ads, but it does not actually increase public safety. This has been shown time and time and time and time again by research.” Longstanding efforts to make Missouri the last state to adopt a prescription drug database to track addictive medications failed. Republican skeptics in the Senate expressed no interest in compromising on the House-backed bill Friday after a feud between the two GOP-led chambers. At issue was a House provision that could thwart efforts to build a wind-energy power line that was slipped onto another Senate bill without senators noticing. Senators on Thursday hurriedly revoked a bill they had just passed, a highly unusual move, when they caught the amendment. Few bills made it across the finish line during lawmaker’s roughly five month session, about 50 compared to more than 90 last year. The Republican-led Legislature this week did succeed in sending a new redistricting plan to the ballot that will ask voters to undo key parts of another redistricting measure they passed less than two years ago. Supporters wanted to accomplish the move this year because new state House and Senate districts will be drawn in 2021. ___ Associated Press writer David A. Lieb contributed to this report.

Ex Output:

Missouri lawmakers OK mail-in voting on final day of work.